Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein

Journal of Experimental Medicine

Volumn 203, Issue 1, 2006, Pages 63-72

  Chang, Hoon Lee ^a   Melchers, Mark ^b   Wang, Hongsheng ^a   Torrey, Ted A ^a   Slota, Rebecca ^b   Qi, Chen Feng ^a   Ji, Young Kim ^c   Lugar, Patricia ^b   Hee, Jeong Kong ^c   Farrington, Lila ^b   Van Der Zouwen, Boris ^b   Zhou, Jeff X ^a   Lougaris, Vassilios ^b   Lipsky, Peter E ^b   Grammer, Amrie C ^b   Morse III, Herbert C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE DEAMINASE; GREEN FLUORESCENT PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER CELL CULTURE; CHROMATIN; CONTROLLED STUDY; GENE CONTROL; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONSIL CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; CYTIDINE DEAMINASE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GERMINAL CENTER; HUMANS; INTERFERON REGULATORY FACTORS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TONSIL;

EID: 31344450346     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051450     Document Type: Article

References (64)

1. MacLennan, I.C.M., A. Gulbransonjudge, K.M. Toellner, M. Casamayorpalleja, E. Chan, D.M.Y. Sze, S.A. Luther, and H.A. Orbea. 1997. The changing preference of T and B cells for partners as T-dependent antibody responses develop. Immunol. Rev. 156:53-66.
2. Lin, K.I., C. Tunyaplin, and K. Calame. 2003. Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol. Rev. 194:19-28.
3. Busslinger, M. 2004. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22:55-79.
4. Shaffer, A.L., X. Yu, Y.S. He, J. Boldrick, E.P. Chan, and L.M. Staudt. 2000. Bcl-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity. 13:199-212.
5. Quezada, S.A., L.Z. Jarvinen, E.E. Lind, and R.J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22:307-328.
6. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:553-563.
7. Reimold, A.M., N.N. Iwakoshi, J. Manis, P. Vallabhajosyula, E. Szomolanyi-Tsuda, E.M. Gravallese, D. Friend, M.J. Grusby, F. Alt, and L.H. Glimcher. 2001. Plasma cell differentiation requires the transcription factor XBP-1. Nature. 412:300-307.
8. Kuppers, R., and R. Dalla-Favera. 2001. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 20:5580-5594.
9. Driggers, P.H., D.L. Ennist, S.L. Gleason, W.-H. Mak, M.S. Marks, B.-Z. Levi, J.R. Flanagan, E. Appella, and K. Ozato. 1990. An interferon γ-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA. 87:3743-3747.
10. Tamura, T., and K. Ozato. 2002. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22:145-152.
11. Levi, B.Z., S. Hashmueli, M. Gleit-Kielmanowicz, A. Azriel, and D. Meraro. 2002. ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. J. Interferon Cytokine Res. 22:153-160.
12. Holtschke, T., J. Lohler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K.P. Knobeloch, L. Gabriele, J.F. Waring, et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell. 87:307-317.
13. Tamura, T., T. Nagamura-Inoue, Z. Shmeltzer, T. Kuwata, and K. Ozato. 2000. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity. 13:155-165.
14. Tsujimura, H., T. Nagamura-Inoue, T. Tamura, and K. Ozato. 2002. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. J. Immunol. 169:1261-1269.
15. + dendritic cells. J. Exp. Med. 196:1415-1425.
16. + dendritic cells. Blood. 101:305-310.
17. Tsujimura, H., T. Tamura, C. Gongora, J. Aliberti, C.R.E. Sousa, A. Sher, and K. Ozato. 2003. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. Blood. 101:961-969.
18. Bovolenta, C., P.H. Driggers, M.S. Marks, J.A. Medin, A.D. Politis, S.N. Vogel, D.E. Levy, K. Sakaguchi, E. Appella, J.E. Coligan, and K. Ozato. 1994. Molecular interactions between interferon consensus sequence binding-protein and members of the interferon regulatory factor family. Proc. Natl. Acad. Sci. USA. 91:5046-5050.
19. Brass, A.L., E. Kehrli, C.F. Eisenbeis, U. Storb, and H. Singh. 1996. Pip, a lymphoid-restricted IRF, contains regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU. 1. Genes Dev. 10:2335-2347.
20. Kuwata, T., C. Gongora, Y. Kanno, K. Sakaguchi, T. Tamura, T. Kanno, V. Basrur, R. Martinez, E. Appella, T. Golub, and K. Ozato. 2002. Gamma interferon triggers interaction between ICSBP (IRF-8) and Tel, recruiting the histone deacetylase HDAC3 to the interferon-responsive element. Mol. Cell. Biol. 22:7439-7448.
21. Zhu, C., K. Rao, H.B. Xiong, K. Gagnidze, F.L. Li, C. Horvath, and S. Plevy. 2003. Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J. Biol. Chem. 278:39372-39382.
22. Cohen, H., A. Azriel, T. Cohen, D. Meraro, S. Hashmueli, D. Bech-Otschir, R. Kraft, W. Dubiel, and B.Z. Levi. 2000. Interaction between interferon consensus sequence-binding protein and Cop9/signalosome subunit CSN2 (Trip15)-a possible link between interferon regulatory factor signaling and the Cop9/signalosome. J. Biol. Chem. 275:39081-39089.
23. Alter-Koltunoff , M., S. Ehrlich, N. Dror, A. Azriel, M. Eilers, H. Hauser, H. Bowen, C.H. Barton, T. Tamura, K. Ozato, and B.Z. Levi. 2003. NRAMP1-mediated innate resistance to intraphagosomal pathogens Is regulated by IRF-8, PU.1, And Miz- 1. J. Biol. Chem. 278:44025-44032.
24. Tamura, T., P. Thotakura, T.S. Tanaka, M.S.H. Ko, and K. Ozato. 2005. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood. 106:1938-1947.
25. Contursi, C., I.M. Wang, L. Gabriele, M. Gadina, J. O'Shea, H.C. Morse, and K. Ozato. 2000. IFN consensus binding protein potentiates STAT1-dependent activation of IFN-γ-responsive promoters in macrophages. Proc. Natl. Acad. Sci. USA. 97:91-96.
26. Rosenbauer, F., J.F. Waring, J. Foerster, M. Wietstruk, D. Philipp, and I. Horak. 1999. Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages. Blood. 94:4274-4281.
27. Burchert, A., D. Cai, L.C. Hofbauer, M.K.R. Samuelsson, E.P. Slater, J. Duyster, M. Ritter, A. Hochhaus, R. Muller, M. Eilers, et al. 2004. Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates Bcl-2. Blood. 103:3480-3489.
28. Schmidt, M., S. Nagel, J. Proba, C. Thiede, M. Ritter, J.F. Waring, F. Rosenbauer, D. Huhn, B. Wittig, I. Horak, and A. Neubauer. 1998. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood. 91:22-29.
29. Schmidt, M., A. Hochhaus, A. Nitsche, R. Hehlmann, and A. Neubauer. 2001. Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α. Blood. 97:3648-3650.
30. Hao, S.X., and R.B. Ren. 2000. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in BCR-ABL-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits BCR-ABL-induced myeloproliferative disorder. Mol. Cell. Biol. 20:1149-1161.
31. Tamura, T., H.J. Kong, C. Tunyaplin, H. Tsujimura, K. Calame, and K. Ozato. 2003. ICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells. Blood. 102:4547-4554.
32. Eisenbeis, C.F., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specifi c, PU.1-dependent transcriptional activator. Genes Dev. 9:1377-1387.
33. Mittrucker, H.W., T. Matsuyama, A. Grossman, T.M. Kundig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P.S. Ohashi, and T.W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:540-543.
34. Lu, R., K.L. Medina, D.W. Lancki, and H. Singh. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17:1703-1708.
35. Pongubala, J.M.R., S. Nagulapalli, M.J. Klemsz, S.R. McKercher, R.A. Maki, and M.L. Atchison. 1992. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol. Cell. Biol. 12:368-378.
36. Eisenbeis, C.F., H. Singh, and U. Storb. 1993. Pu.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol. Cell. Biol. 13:6452-6461.
37. Nagulapalli, S., and M.L. Atchison. 1998. Transcription factor PIP can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol. Cell. Biol. 18:4639-4650.
38. Zhan, F., E.M. Tian, K. Bumm, R. Smith, B. Barlogie, and J. Shaughnessy Jr. 2003. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood. 101:1128-1140.
39. Morse, H.C., III, T. McCarty, C.F. Qi, T.A. Torrey, Z.N. Naghashfar, S.K. Chattopadhyay, T.N. Fredrickson, and J.W. Hartley. 2003. B lymphoid neoplasms of mice: characteristics of naturally occurring and engineered diseases and relationships to human disorders. Adv. Immunol. 81:97-121.
40. Zhang, J.Q., C. Okumura, T. McCarty, T.A. Torrey, M.S. Shin, C.H. Lee, M. Hori, Z. Naghashfar, D.C. Roopenian, H.C. Morse III, and W.F. Davidson. 2004. Evidence for selective transformation of autoreactive immature plasma cells in mice deficient in Fasl. J. Exp. Med. 200:1467-1478.
41. Grammer, A.C., R. Fischer, O. Lee, X. Zhang, and P.E. Lipsky. 2004. Flow cytometric assessment of the signaling status of human B lymphocytes from normal and autoimmune individuals. Arthritis Res. Ther. 6:28-38.
42. Grammer, A.C., R.D. McFarland, J. Heaney, B.F. Darnell, and P.E. Lipsky. 1999. Expression, regulation, and function of B cell-expressed CD154 in germinal centers. J. Immunol. 163:4150-4159.
43. Shin, M.S., T.N. Fredrickson, J.W. Hartley, T. Suzuki, K. Agaki, and H.C. Morse III. 2004. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res. 64:4419-4427.
44. Morse, H.C., M.R. Anver, T.N. Fredrickson, D.C. Haines, A.W. Harris, N.L. Harris, E.S. Jaffe, S.C. Kogan, I.C.M. MacLennan, P.K. Pattengale, and J.M. Ward. 2002. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 100:246-258.
45. Feldhahn, N., I. Schwering, S. Lee, M. Wartenberg, F. Klein, H. Wang, G.L. Zhou, S.M. Wang, J.D. Rowley, J. Hescheler, et al. 2002. Silencing of B cell receptor signals in human naive B cells. J. Exp. Med. 196:1291-1305.
46. Klein, U., Y.H. Tu, G.A. Stolovitzky, J.L. Keller, J. Haddad, V. Miljkovic, G. Cattoretti, A. Califano, and R. Dalla-Favera. 2003. Transcriptional analysis of the B cell germinal center reaction. Proc. Natl. Acad. Sci. USA. 100:2639-2644.
47. Zhu, C., G. Saberwal, Y.F. Lu, L.C. Platanias, and E.A. Eklund. 2004. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1. J. Biol. Chem. 279:50874-50885.
48. Tarte, K., J. De Vos, T. Thykjaer, F. Zhan, G. Fiol, V. Costes, T. Reme, E. Legouffe, J.-F. Rossi, J. Shaughnessy Jr., et al. 2002. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood. 100:1113-1122.
49. Tarte, K., F. Zhan, J. De Vos, B. Klein, and J. Shaughnessy. 2003. Gene expression profi ling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood. 102:592-600.
50. Allman, D., A. Jain, A. Dent, R.R. Maile, T. Selvaggi, M.R. Kehry, and L.M. Staudt. 1996. BCL-6 expression during B-cell activation. Blood. 87:5257-5268.
51. Niu, H., B.H. Ye, and R. Dalla-Favera. 1998. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor. Genes Dev. 12:1953-1961.
52. Bereshchenko, O.R., W. Gu, and R. Dalla-Favera. 2002. Acetylation inactivates the transcriptional repressor BCL 6. Nat. Genet. 32:606-613.
53. Falini, B., M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti, M. Gambacorta, R. Pacini, C. Alunni, L. Natali-Tanci, B. Ugolini, et al. 2000. A monoclonal antibody (Mum1p) detects expression of the Mum 1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 95:2084-2092.
54. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (Aid), a potential RNA editing enzyme. Cell. 102:553-563.
55. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Lagelouse, A. Gennery, et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell. 102:565-575.
56. Muramatsu, M., V.S. Sankaranand, S. Anant, M. Sugai, K. Kinoshita, N.O. Davidson, and T. Honjo. 1999. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274:18470-18476.
57. Dedeoglu, F., B. Horwitz, J. Chaudhuri, F.W. Alt, and R.S. Geha. 2004. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NF-κB. Int. Immunol. 16:395-404.
58. Litinskiy, M.B., B. Nardelli, D.M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLys and April. Nat. Immunol. 3:822-829.
59. Ozaki, K., R. Spolski, R. Ettinger, H.P. Kim, G. Wang, C.F. Qi, P. Hwu, D.J. Shaffer, S. Akilesh, D.C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl 6. J. Immunol. 173:5361-5371.
60. Giese, N.A., L. Gabriele, T.M. Doherty, D.M. Klinman, L. Tadesse-Heath, C. Contursi, S.L. Epstein, and H.C. Morse III. 1997. Interferon (IFN) consensus sequence binding-protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186:1535-1546.
61. Pernis, A.B. 2002. The role of IRF-4 in B and T cell activation and differentiation. J. Interferon Cytokine Res. 22:111-120.
62. Gupta, S., M. Jiang, A. Anthony, and A.B. Pernis. 1999. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 190:1837-1848.
63. Gordon, C.J., G. Grafton, P.M. Wood, M. Larche, and R.J. Armitage. 2001. Modelling the human immune response: can mice be trusted? Curr. Opin. Pharmacol. 1:431-438.
64. Mestas, J., and C.C.W. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172:2731-2738.